Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
1.092 Leser
Artikel bewerten:
(2)

Appian Corporation: Deloitte and Appian Form Strategic Alliance to Modernize Mission Systems for Government and Commercial Clients

Together, these organizations are helping clients strategically revamp business processes through a low-code center of excellence

TYSONS, Va., March 10, 2020 (GLOBE NEWSWIRE) -- Deloitte Consulting, LLP and Appian (NASDAQ: APPN) today announced a strategic alliance to help modernize mission systems for its clients within commercial, federal civilian, defense, state and local government agencies. Working together, these organizations are providing clients with the ability to modernize their systems through low-code development and intelligent automation, which ranges across several technologies including artificial intelligence (AI), robotic process automation (RPA), robotic workforce management (RWM) and more.

This alliance showcases the power of low-code at the center of IT modernization and digital transformation. Deloitte recently established an Appian Solutions Incubator to build application accelerators, templates, and reusable solutions. These will accelerate the modernization process in order to help provide clients with a fast and efficient way to revamp business processes and improve workflow.

"Government entities are focused on IT modernization but often have challenges due to legacy systems," said Kerri Maloney, Deloitte Consulting LLP's Government & Public Services Lead Alliance Partner. "Appian helps us offer our clients a solution for modernizing systems quickly and seamlessly. Together, we are working with some of the largest federal agencies to transform their automation strategies and create more agile processes."

Currently, Deloitte and Appian are collaborating with the Food and Drug Administration (FDA) to upgrade their legacy systems and implement new technologies by leveraging robotic process automation (RPA). Specifically, the FDA Center for Drug Evaluation and Research (CDER) is utilizing the Appian platform to modernize their existing systems.

"Deloitte provides a superior level of excellence in providing IT services to the government and we are proud to partner with them," said Marc Wilson, Founder and SVP of Global Partnerships and Industries. "We have been working in the public sector for decades, with several large clients, and this alliance is a true testament to the power of what can happen when we come together to help organizations become more agile through automation."

To learn more about Appian's work within the public sector, click here.

About Appian

Appian provides a low-code development platform that accelerates the creation of high-impact business applications. Many of the world's largest organizations use Appian applications to improve customer experience, achieve operational excellence, and simplify global risk management and compliance. www.appian.com

For Information Contact:
Nicole Greggs
Director of Media Relations
+1 703-260-7868
nicole.greggs@appian.com

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2020 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.